Teligent
TLGT
#10190
Rank
$16.1 M
Marketcap
$0.17
Share price
-13.85%
Change (1 day)
1,600.00%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -$43.98 Million USD

According to Teligent's latest financial reports the company's current earnings are $46.29 Million USD. In 2020 the company made an earning of -$38.41 Million USD a decrease over its 2019 earnings that were of -$8.02 Million USD.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-$43.98 Million14.49%
2020-$38.41 Million378.89%
2019-$8.02 Million-46.87%
2018-$15.1 Million10.47%
2017-$13.67 Million-637.49%
2016$2.54 M-179.64%
2015-$3.2 Million-181.72%
2014$3.9 M-4806.02%
2013-$0.09 Million-97.35%
2012-$3.14 Million6.23%
2011-$2.96 Million-18.59%
2010-$3.63 Million-11.37%
2009-$4.1 Million98.4%
2008-$2.07 Million156.15%
2007-$0.81 Million-59.36%
2006-$1.99 Million17.92%
2005-$1.68 Million37.7%
2004-$1.22 Million25.51%
2003-$0.98 Million-289.84%
2002$0.51 M-1605.88%
2001-$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-$0.16 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$18.16 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA